vs
BALCHEM CORP（BCPC）与PROG Holdings, Inc.（PRG）财务数据对比。点击上方公司名可切换其他公司
PROG Holdings, Inc.的季度营收约是BALCHEM CORP的2.5倍（$651.6M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs 5.5%，领先9.3%），BALCHEM CORP同比增速更快（9.8% vs -19.6%），过去两年PROG Holdings, Inc.的营收复合增速更高（4.9% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
PROG Holdings是一家总部位于美国的金融科技企业，主要面向美国本土市场提供灵活的租购及销售点融资解决方案，核心业务涵盖零售合作伙伴融资、消费信贷与支付服务，帮助消费者无需满足传统信用要求即可购买电子产品、家居用品等商品。
BCPC vs PRG — 直观对比
营收规模更大
PRG
是对方的2.5倍
$263.6M
营收增速更快
BCPC
高出29.5%
-19.6%
净利率更高
BCPC
高出9.3%
5.5%
两年增速更快
PRG
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $651.6M |
| 净利润 | $39.2M | $36.1M |
| 毛利率 | 35.6% | — |
| 营业利润率 | 19.8% | 10.0% |
| 净利率 | 14.9% | 5.5% |
| 营收同比 | 9.8% | -19.6% |
| 净利润同比 | 16.8% | 3.8% |
| 每股收益（稀释后） | $1.21 | $3.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCPRG
| Q1 26 | — | $651.6M | ||
| Q4 25 | $263.6M | $525.4M | ||
| Q3 25 | $267.6M | $595.1M | ||
| Q2 25 | $255.5M | $604.7M | ||
| Q1 25 | $250.5M | $684.1M | ||
| Q4 24 | $240.0M | $558.9M | ||
| Q3 24 | $239.9M | $606.1M | ||
| Q2 24 | $234.1M | $592.2M |
净利润BCPCPRG
| Q1 26 | — | $36.1M | ||
| Q4 25 | $39.2M | $40.5M | ||
| Q3 25 | $40.3M | $33.1M | ||
| Q2 25 | $38.3M | $38.5M | ||
| Q1 25 | $37.1M | $34.7M | ||
| Q4 24 | $33.6M | $57.5M | ||
| Q3 24 | $33.8M | $84.0M | ||
| Q2 24 | $32.1M | $33.8M |
毛利率BCPCPRG
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
营业利润率BCPCPRG
| Q1 26 | — | 10.0% | ||
| Q4 25 | 19.8% | 6.9% | ||
| Q3 25 | 20.4% | 9.0% | ||
| Q2 25 | 20.1% | 10.0% | ||
| Q1 25 | 20.4% | 8.2% | ||
| Q4 24 | 19.8% | 8.9% | ||
| Q3 24 | 20.0% | 8.1% | ||
| Q2 24 | 19.6% | 9.4% |
净利率BCPCPRG
| Q1 26 | — | 5.5% | ||
| Q4 25 | 14.9% | 7.7% | ||
| Q3 25 | 15.1% | 5.6% | ||
| Q2 25 | 15.0% | 6.4% | ||
| Q1 25 | 14.8% | 5.1% | ||
| Q4 24 | 14.0% | 10.3% | ||
| Q3 24 | 14.1% | 13.9% | ||
| Q2 24 | 13.7% | 5.7% |
每股收益（稀释后）BCPCPRG
| Q1 26 | — | $3.68 | ||
| Q4 25 | $1.21 | $0.99 | ||
| Q3 25 | $1.24 | $0.82 | ||
| Q2 25 | $1.17 | $0.95 | ||
| Q1 25 | $1.13 | $0.83 | ||
| Q4 24 | $1.03 | $1.33 | ||
| Q3 24 | $1.03 | $1.94 | ||
| Q2 24 | $0.98 | $0.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $69.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $774.4M |
| 总资产 | $1.7B | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCPRG
| Q1 26 | — | $69.4M | ||
| Q4 25 | $74.6M | $308.8M | ||
| Q3 25 | $65.1M | $292.6M | ||
| Q2 25 | $65.4M | $222.0M | ||
| Q1 25 | $49.9M | $213.3M | ||
| Q4 24 | $49.5M | $90.9M | ||
| Q3 24 | $73.7M | $221.7M | ||
| Q2 24 | $63.7M | $250.1M |
总债务BCPCPRG
| Q1 26 | — | — | ||
| Q4 25 | — | $594.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $643.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益BCPCPRG
| Q1 26 | — | $774.4M | ||
| Q4 25 | $1.3B | $746.4M | ||
| Q3 25 | $1.3B | $703.6M | ||
| Q2 25 | $1.3B | $668.7M | ||
| Q1 25 | $1.2B | $654.4M | ||
| Q4 24 | $1.1B | $650.3M | ||
| Q3 24 | $1.2B | $630.8M | ||
| Q2 24 | $1.1B | $581.9M |
总资产BCPCPRG
| Q1 26 | — | $2.0B | ||
| Q4 25 | $1.7B | $1.6B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.6B | $1.5B |
负债/权益比BCPCPRG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.99× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BCPCPRG
| Q1 26 | — | — | ||
| Q4 25 | $67.3M | $-54.9M | ||
| Q3 25 | $65.6M | $110.0M | ||
| Q2 25 | $47.3M | $69.9M | ||
| Q1 25 | $36.5M | $209.9M | ||
| Q4 24 | $52.3M | $-84.5M | ||
| Q3 24 | $51.3M | $31.9M | ||
| Q2 24 | $45.0M | $55.4M |
自由现金流BCPCPRG
| Q1 26 | — | — | ||
| Q4 25 | — | $-57.5M | ||
| Q3 25 | — | $106.5M | ||
| Q2 25 | — | $68.0M | ||
| Q1 25 | — | $208.0M | ||
| Q4 24 | — | $-86.8M | ||
| Q3 24 | — | $29.8M | ||
| Q2 24 | — | $53.5M |
自由现金流率BCPCPRG
| Q1 26 | — | — | ||
| Q4 25 | — | -10.9% | ||
| Q3 25 | — | 17.9% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 30.4% | ||
| Q4 24 | — | -15.5% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 9.0% |
资本支出强度BCPCPRG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.3% |
现金转化率BCPCPRG
| Q1 26 | — | — | ||
| Q4 25 | 1.72× | -1.36× | ||
| Q3 25 | 1.63× | 3.32× | ||
| Q2 25 | 1.23× | 1.82× | ||
| Q1 25 | 0.98× | 6.05× | ||
| Q4 24 | 1.56× | -1.47× | ||
| Q3 24 | 1.52× | 0.38× | ||
| Q2 24 | 1.40× | 1.64× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
PRG
暂无分部数据
